Why Illumina Rose 18.7% in August
Shares of Illumina (NASDAQ: ILMN), a leading manufacturer of genetic testing equipment, rose 18.7% in August, according to data from S&P Global Market Intelligence. Investors can thank solid second-quarter results and bullish guidance for the big jump.
Here's a review of the key takeaways from the company's impressive second quarter:
Given the estimate topping results and bullish revenue guidance, it isn't hard to figure out why shareholders had a great month.
Source: Fool.com
Illumina Inc. Stock
€98.96
-3.520%
With 22 Buy predictions and 4 Sell predictions Illumina Inc. is one of the favorites of our community.
With a target price of 163 € there is a hugely positive potential of 64.71% for Illumina Inc. compared to the current price of 98.96 €.
